Undercarboxylated osteocalcin is associated with vascular function in female older adults but does not influence vascular function in male rabbit carotid artery ex vivo.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
19
08
2020
accepted:
09
11
2020
entrez:
25
11
2020
pubmed:
26
11
2020
medline:
5
1
2021
Statut:
epublish
Résumé
There are conflicting reports on the association of undercarboxylated osteocalcin (ucOC) in cardiovascular disease development, including endothelial function and hypertension. We tested whether ucOC is related to blood pressure and endothelial function in older adults, and if ucOC directly affects endothelial-mediated vasodilation in the carotid artery of rabbits. In older adults, ucOC, blood pressure, pulse wave velocity (PWV) and brachial artery flow-mediated dilation (BAFMD) were measured (n = 38, 26 post-menopausal women and 12 men, mean age 73 ± 0.96). The vasoactivity of the carotid artery was assessed in male New Zealand White rabbits following a four-week normal or atherogenic diet using perfusion myography. An ucOC dose response curve (0.3-45 ng/ml) was generated following incubation of the arteries for 2-hours in either normal or high glucose conditions. ucOC levels were higher in normotensive older adults compared to those with stage 2 hypertension (p < 0.05), particularly in women (p < 0.01). In all participants, higher ucOC was associated with lower PWV (p < 0.05), but not BAFMD (p > 0.05). In rabbits, ucOC at any dose did not alter vasoactivity of the carotid artery, either following a normal or an atherogenic diet (p > 0.05). Increased ucOC is associated with lower blood pressure and increased arterial stiffness, particularly in post-menopausal women. However, ucOC administration has no direct short-term effect on endothelial function in rabbit arteries. Future studies should explore whether treatment with ucOC, in vivo, has direct or indirect effects on blood vessel function.
Sections du résumé
BACKGROUND
There are conflicting reports on the association of undercarboxylated osteocalcin (ucOC) in cardiovascular disease development, including endothelial function and hypertension. We tested whether ucOC is related to blood pressure and endothelial function in older adults, and if ucOC directly affects endothelial-mediated vasodilation in the carotid artery of rabbits.
METHODS
In older adults, ucOC, blood pressure, pulse wave velocity (PWV) and brachial artery flow-mediated dilation (BAFMD) were measured (n = 38, 26 post-menopausal women and 12 men, mean age 73 ± 0.96). The vasoactivity of the carotid artery was assessed in male New Zealand White rabbits following a four-week normal or atherogenic diet using perfusion myography. An ucOC dose response curve (0.3-45 ng/ml) was generated following incubation of the arteries for 2-hours in either normal or high glucose conditions.
RESULTS
ucOC levels were higher in normotensive older adults compared to those with stage 2 hypertension (p < 0.05), particularly in women (p < 0.01). In all participants, higher ucOC was associated with lower PWV (p < 0.05), but not BAFMD (p > 0.05). In rabbits, ucOC at any dose did not alter vasoactivity of the carotid artery, either following a normal or an atherogenic diet (p > 0.05).
CONCLUSION
Increased ucOC is associated with lower blood pressure and increased arterial stiffness, particularly in post-menopausal women. However, ucOC administration has no direct short-term effect on endothelial function in rabbit arteries. Future studies should explore whether treatment with ucOC, in vivo, has direct or indirect effects on blood vessel function.
Identifiants
pubmed: 33237935
doi: 10.1371/journal.pone.0242774
pii: PONE-D-20-25843
pmc: PMC7688178
doi:
Substances chimiques
BGLAP protein, human
0
Osteocalcin
104982-03-8
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0242774Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Clin Endocrinol Metab. 2009 Jan;94(1):45-9
pubmed: 18984661
Cardiovasc Diabetol. 2014 Apr 07;13:74
pubmed: 24708830
Bone. 2020 Jan;130:115085
pubmed: 31622778
Int J Mol Sci. 2019 Sep 11;20(18):
pubmed: 31514440
Kidney Blood Press Res. 2010;33(1):66-71
pubmed: 20197689
Sci Rep. 2020 Feb 4;10(1):1840
pubmed: 32020009
Cell Metab. 2013 Jan 8;17(1):20-33
pubmed: 23312281
Diabetes Metab. 2012 Feb;38(1):76-81
pubmed: 21996253
Front Endocrinol (Lausanne). 2017 Jul 31;8:183
pubmed: 28824544
Osteoporos Int. 2017 Aug;28(8):2265-2273
pubmed: 28289780
Bone. 2012 Feb;50(2):568-75
pubmed: 21550430
J Clin Endocrinol Metab. 1998 Sep;83(9):3258-66
pubmed: 9745439
Hypertension. 2010 May;55(5):1075-85
pubmed: 20351340
J Clin Endocrinol Metab. 2013 Mar;98(3):1084-92
pubmed: 23386651
J Bone Miner Metab. 2018 May;36(3):352-363
pubmed: 28642975
Diabetes Res Clin Pract. 2011 Jun;92(3):393-9
pubmed: 21466902
Calcif Tissue Int. 2019 Nov;105(5):546-556
pubmed: 31485687
Nutrients. 2020 Jul 16;12(7):
pubmed: 32708633
Nutrients. 2018 Jun 29;10(7):
pubmed: 29966260
Front Endocrinol (Lausanne). 2017 Nov 22;8:330
pubmed: 29204135
Blood Press. 2018 Apr;27(2):106-111
pubmed: 29172726
Exp Clin Endocrinol Diabetes. 2017 Apr;125(4):234-240
pubmed: 28073125
PLoS Genet. 2020 May 28;16(5):e1008586
pubmed: 32463816
PLoS Genet. 2020 May 28;16(5):e1008361
pubmed: 32463812
Cell. 2007 Aug 10;130(3):456-69
pubmed: 17693256
J Cell Physiol. 2020 Sep 16;:
pubmed: 32936958
J Bone Miner Metab. 2016 Jul;34(4):367-79
pubmed: 26747614
J Bone Miner Metab. 2018 Jul;36(4):470-477
pubmed: 28766135
Nutrients. 2018 Oct 04;10(10):
pubmed: 30287742
Atherosclerosis. 2016 May;248:97-109
pubmed: 26994427
J Clin Endocrinol Metab. 2016 Jan;101(1):96-102
pubmed: 26529629
Int J Exp Pathol. 2009 Jun;90(3):311-20
pubmed: 19563613
Menopause. 2013 Nov;20(11):1194-9
pubmed: 23571521
Pulse (Basel). 2017 Jan;4(4):180-192
pubmed: 28229053
Ann Intern Med. 2018 Mar 6;168(5):351-358
pubmed: 29357392
Clin Endocrinol (Oxf). 2015 Sep;83(3):320-6
pubmed: 25868823
J Clin Endocrinol Metab. 2015 Jan;100(1):63-71
pubmed: 25365314